158 related articles for article (PubMed ID: 7822013)
21. Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).
McCullough MJ; Clemons KV; McCusker JH; Stevens DA
J Clin Microbiol; 1998 Sep; 36(9):2613-7. PubMed ID: 9705402
[TBL] [Abstract][Full Text] [Related]
22. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa.
Larsen GL; Mitchell BC; Harper TB; Henson PM
Am Rev Respir Dis; 1982 Aug; 126(2):306-11. PubMed ID: 7103255
[TBL] [Abstract][Full Text] [Related]
23. A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration.
Mastellos D; Papadimitriou JC; Franchini S; Tsonis PA; Lambris JD
J Immunol; 2001 Feb; 166(4):2479-86. PubMed ID: 11160308
[TBL] [Abstract][Full Text] [Related]
24. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component.
Lyon FL; Hector RF; Domer JE
J Med Vet Mycol; 1986 Oct; 24(5):359-67. PubMed ID: 3537260
[TBL] [Abstract][Full Text] [Related]
25. Role of Murine Complement Component C5 in Acute
de Castro ÍA; Bavia L; Fraga TR; Amano MT; Breda LCD; Granados-Martinez AP; da Silva AMG; Vasconcellos SA; Isaac L
Front Cell Infect Microbiol; 2018; 8():63. PubMed ID: 29568732
[TBL] [Abstract][Full Text] [Related]
26. Immunoproteomic profiling of Saccharomyces cerevisiae systemic infection in a murine model.
Hernández-Haro C; Llopis S; Molina M; Monteoliva L; Gil C
J Proteomics; 2015 Jan; 112():14-26. PubMed ID: 25173100
[TBL] [Abstract][Full Text] [Related]
27. Review of current methods for characterizing virulence and pathogenicity potential of industrial Saccharomyces cerevisiae strains towards humans.
Anoop V; Rotaru S; Shwed PS; Tayabali AF; Arvanitakis G
FEMS Yeast Res; 2015 Sep; 15(6):. PubMed ID: 26195617
[TBL] [Abstract][Full Text] [Related]
28. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
Cardozo C; Edelman J; Jagirdar J; Lesser M
Am Rev Respir Dis; 1991 Jul; 144(1):173-8. PubMed ID: 2064126
[TBL] [Abstract][Full Text] [Related]
29. A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors.
de Llanos R; Fernández-Espinar MT; Querol A
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):221-31. PubMed ID: 16871421
[TBL] [Abstract][Full Text] [Related]
30. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice.
Evans R
Int J Cancer; 1980 Aug; 26(2):227-9. PubMed ID: 7203715
[TBL] [Abstract][Full Text] [Related]
31. The effect of intravascular complement activation and brief episodes of hypoxia on protein in bronchoalveolar lavage fluid in C5 sufficient and deficient mice.
Larsen GL; Presley DM; Graves JP; Giclas PC
Pediatr Pulmonol; 1991; 11(4):302-9. PubMed ID: 1758754
[TBL] [Abstract][Full Text] [Related]
32. Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae.
McCusker JH; Clemons KV; Stevens DA; Davis RW
Infect Immun; 1994 Dec; 62(12):5447-55. PubMed ID: 7960125
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory properties of Nocardia lysozyme digest (NLD) in complement normal and C5-deficient mice.
Georgieva P; Ivanovska N; Barot-Ciorbaru R
Vaccine; 1998 Jul; 16(11-12):1237-42. PubMed ID: 9682384
[TBL] [Abstract][Full Text] [Related]
34. A Saccharomyces cerevisiae mutant with increased virulence.
Wheeler RT; Kupiec M; Magnelli P; Abeijon C; Fink GR
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2766-70. PubMed ID: 12589024
[TBL] [Abstract][Full Text] [Related]
35. C5 gene influences the development of murine myasthenia gravis.
Christadoss P
J Immunol; 1988 Apr; 140(8):2589-92. PubMed ID: 3356901
[TBL] [Abstract][Full Text] [Related]
36. Tritiated thymidine incorporation and the development of an interstitial lesion in the bronchiolar-alveolar regions of the lungs of normal and complement deficient mice after inhalation of chrysotile asbestos.
McGavran PD; Butterick CJ; Brody AR
J Environ Pathol Toxicol Oncol; 1989 Dec; 9(5-6):377-91. PubMed ID: 2637933
[TBL] [Abstract][Full Text] [Related]
37. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis.
Hector RF; Yee E; Collins MS
Infect Immun; 1990 May; 58(5):1476-8. PubMed ID: 2323826
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity.
Tsuji RF; Kikuchi M; Askenase PW
J Immunol; 1996 Jun; 156(12):4444-50. PubMed ID: 8648091
[TBL] [Abstract][Full Text] [Related]
39. Genetic control of lipopolysaccharide-induced mobilization of CFUs. Dissociation between early and delayed mobilization of CFUs in complement C5-deficient mice and LPS non-responder mice.
Benner R; Rijnbeek AM; Molendijk W; Vos O
Cell Tissue Kinet; 1981 Mar; 14(2):143-51. PubMed ID: 7471163
[TBL] [Abstract][Full Text] [Related]
40. Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis.
Watson WC; Brown PS; Pitcock JA; Townes AS
Arthritis Rheum; 1987 Apr; 30(4):460-5. PubMed ID: 3580014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
